| Followers | 99 |
| Posts | 11370 |
| Boards Moderated | 0 |
| Alias Born | 02/18/2016 |
Wednesday, June 11, 2025 4:14:56 PM
Don't assume something negative when it doesn't fit your goals!! First there are plenty of companies that do offerings over their share price!! Instead of doing some research you went on the attack!! Good luck!!
Recent KLTO News
- Klotho Neurosciences Completes Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML • PR Newswire (US) • 03/12/2026 02:27:00 PM
- Klotho Neurosciences to acquire Greenland Mines, adding major Greenland metals project • IH Market News • 03/04/2026 03:55:17 PM
- KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE CORRIDOR • PR Newswire (US) • 03/04/2026 01:00:00 PM
- Klotho Neurosciences advances epigenetic diagnostics with development of AI-driven “Klotho Clock” • IH Market News • 02/24/2026 03:25:17 PM
- Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI) • PR Newswire (US) • 02/24/2026 01:00:00 PM
- Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein ("s-KL") Isoform of the Human Klotho Gene Sequence • PR Newswire (US) • 02/18/2026 01:00:00 PM
- Klotho Neurosciences to Present at the Biotech Showcase 2026 • PR Newswire (US) • 01/08/2026 01:00:00 PM
- Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award • PR Newswire (US) • 11/07/2025 03:03:00 PM
- Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston • PR Newswire (US) • 10/16/2025 12:00:00 PM
- Klotho Neurosciences Announces Expiration of Letter of Intent • PR Newswire (US) • 10/07/2025 10:20:00 PM
- Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership • PR Newswire (US) • 09/30/2025 12:30:00 PM
- Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar • PR Newswire (US) • 09/08/2025 12:00:00 PM
- Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar • PR Newswire (US) • 09/08/2025 12:00:00 PM
- Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market • PR Newswire (US) • 08/18/2025 12:30:00 PM
- Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology • PR Newswire (US) • 08/12/2025 10:00:00 AM
- Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology • PR Newswire (US) • 07/26/2025 01:05:00 AM
- Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology • PR Newswire (US) • 07/24/2025 05:30:00 PM
- Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets • PR Newswire (US) • 07/22/2025 02:21:00 PM
- Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules • PR Newswire (US) • 07/16/2025 10:00:00 AM
- Klotho Neurosciences Shares Jump as FDA Grants Orphan Drug Status for ALS Therapy • IH Market News • 07/10/2025 12:52:01 PM
- Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease") • PR Newswire (US) • 07/10/2025 09:00:00 AM
- Biotech Stock Rips Following Key Announcement • AllPennyStocks.com • 06/30/2025 04:30:00 PM
- Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS • PR Newswire (US) • 06/30/2025 06:00:00 AM
- Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population • PR Newswire (US) • 06/24/2025 09:00:00 AM
- Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population • PR Newswire (US) • 06/24/2025 09:00:00 AM
